InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,178.00
(
1.16%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.19
(
-1.27%
)
Bitcoin
61,939.15
(
2.78%
)
Post# of 648134
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

califax

Send PM Follow Ignore
Followers 24
Posts 3015
Boards Moderated 0
Alias Born 01/18/2009

califax

Re: califax post# 145878

Monday, 10/10/2011 11:07:11 AM

Monday, October 10, 2011 11:07:11 AM

Post# of 648134
APRI - Apricus Biosciences Announces Presentation of Efficacy and Clinical Safety Data for Vitaros(R) at Upcoming Industry Conference

http://ih.advfn.com/p.php?pid=nmona&article=49481882

...The poster presentation will discuss additional subgroup analyses on a combined dataset from two pivotal Phase 3 clinical trials in 1,732 patients suffering from erectile dysfunction ("ED"). The data further demonstrates the efficacy and safety of Vitaros® as an easy-to-administer, topical first-line treatment option for all ED patients, independent of age, body mass index ("BMI") and risk factors, such as cardiovascular disease and diabetes.

posts are IMHO // either news - with LINK

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up